Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Weight Loss, Satiety, and the Postprandial Gut Hormone Response After Esophagectomy A Prospective Study

Artikel i vetenskaplig tidskrift
Författare J. A. Elliott
N. G. Docherty
H. G. Eckhardt
S. L. Doyle
E. M. Guinan
N. Ravi
J. V. Reynolds
Carel W le Roux
Publicerad i Annals of Surgery
Volym 266
Nummer/häfte 1
Sidor 82-90
ISSN 0003-4932
Publiceringsår 2017
Publicerad vid Institutionen för kliniska vetenskaper, sektionen för kirurgi och kirurgisk gastroforskning, Avdelningen för gastrokirurgisk forskning och utbildning
Sidor 82-90
Språk English
Länkar doi.org/10.1097/sla.000000000000191...
Ämnesord appetite, body weight, dumping syndrome, enteroendocrine cell, esophageal cancer, esophagectomy, gastrointestinal symptoms, GLP-1, glucagon-like peptide 1, glucose, gut hormones, gut peptides, health-related quality of life, hunger, insulin, L-cell, mal, glucagon-like peptide-1, gastric bypass, intestinal transit, total, gastrectomy, symptoms, glucose, Surgery, holic j, 1991, digestive diseases and sciences, v36, p1361, holic j, 1993, digestion, v54, p73
Ämneskategorier Endokrinologi och diabetes

Sammanfattning

Objective: To prospectively characterize changes in body weight, satiety, and postprandial gut hormone profiles following esophagectomy. Background: With improved oncologic outcomes in esophageal cancer, there is an increasing focus on functional status and health-related quality of life in survivorship. Early satiety and weight loss are common after esophagectomy, but the pathophysiology of these phenomena remains poorly understood. Methods: In this prospective study, consecutive patients undergoing esophagectomy with gastric conduit reconstruction were studied preoperatively and at 10 days, 6 weeks, and 3 months postoperatively. Glucagon-like peptide 1 (GLP-1) immunoreactivity of plasma collected immediately before and at 15, 30, 60, 90, 120, 150, and 180 minutes after a standardized 400-kcal mixed meal was determined. Gastrointestinal symptom scores were computed using European Organization for Research and Treatment of Cancer questionnaires. Results: Body weight loss at 6 weeks and 3 months postoperatively among 13 patients undergoing esophagectomy was 11.1 +/- 2.3% (P < 0.001) and 16.3 +/- 2.2% (P < 0.0001), respectively. Early satiety (P = 0.043), gastrointestinal pain and discomfort (P = 0.01), altered taste (P = 0.006), and diarrhea (P = 0.038) scores increased at 3 months postoperatively. Area under the curve for the satiety gut hormone GLP-1 was significantly increased from 10 days postoperatively (2.4 +/- 0.2-fold increase, P < 0.01), and GLP-1 peak increased 3.8 +/- 0.6-, 4.7 +/- 0.8-, and 4.4 +/- 0.5-fold at 10 days, 6 weeks, and 3 months postoperatively (all P < 0.0001). Three months postoperatively, GLP-1 area under the curve was associated with early satiety (P = 0.0002, R-2 = 0.74), eating symptoms (P = 0.007, R-2 = 0.54), and trouble enjoying meals (P = 0.0004, R-2 = 0.73). Conclusions: After esophagectomy, patients demonstrate an exaggerated postprandial satiety gut hormone response, which may mediate postoperative changes in satiety, body weight, and gastrointestinal quality of life.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?